Literature DB >> 7890773

Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).

S D Shapiro1, C J Fliszar, T J Broekelmann, R P Mecham, R M Senior, H G Welgus.   

Abstract

The matrix metalloproteinase 92-kDa gelatinase is a major product of inflammatory cells. Macrophages synthesize and secrete this proteinase as a proenzyme in association with tissue inhibitor of metalloproteinases (TIMP) (92TIMP), whereas neutrophils store and release it from secondary granules as a TIMP-free proenzyme (92TIMP-free). Metalloproteinase proenzymes can be activated in vitro by a variety of agents, including organomercurials and proteinases, resulting in loss of an 8-10-kDa NH2-terminal domain which disrupts the interaction of a conserved cysteine residue with the catalytic zinc molecule. We report that the activation and processing of 92-kDa gelatinase differs depending on its association with TIMP and the nature of the activating agent. We observed that 92TIMP undergoes classic activation to 82 kDa by stromelysin, whereas exposure to 4-aminophenylmercuric acetate (APMA) results in a final product of 83 kDa that still contains the "prodomain" cysteine. Association with TIMP appears to stabilize the COOH-terminal domain, whereas 92TIMP-free is converted by APMA to a final product of 67 kDa lacking the COOH-terminal portion. In the continued presence of APMA, which maintains cysteine-zinc disruption, the 67-kDa species is at least as active as the classic 82 kDa. In contrast, activation of 92TIMP-free by stromelysin initially generates the 82-kDa form which is followed by final conversion to a 50-kDa species that lacks the catalytic domain of the parent molecule. Therefore, although stromelysin activation of 92TIMP-free is initially efficient, the active 82-kDa form is short-lived and is replaced by an inactive 50-kDa product. This complex pattern of activation of the 92-kDa gelatinase may serve to restrict its proteolytic capacity following exposure to stromelysin and may serve to regulate proteinase activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890773     DOI: 10.1074/jbc.270.11.6351

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Cadherin-6B proteolytic N-terminal fragments promote chick cranial neural crest cell delamination by regulating extracellular matrix degradation.

Authors:  Andrew T Schiffmacher; Ashrifia Adomako-Ankomah; Vivien Xie; Lisa A Taneyhill
Journal:  Dev Biol       Date:  2018-06-27       Impact factor: 3.582

3.  Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.

Authors:  G Sehgal; J Hua; E J Bernhard; I Sehgal; T C Thompson; R J Muschel
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.

Authors:  Vincent Fontaine; Marie-Paule Jacob; Xavier Houard; Patrick Rossignol; Didier Plissonnier; Eduardo Angles-Cano; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice.

Authors:  Johannes F M Pruijt; Perry Verzaal; Ronald van Os; Evert-Jan F M de Kruijf; Marianke L J van Schie; Alberto Mantovani; Annunciata Vecchi; Ivan J D Lindley; Roel Willemze; Sofie Starckx; Ghislain Opdenakker; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

6.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

Authors:  R Pyo; J K Lee; J M Shipley; J A Curci; D Mao; S J Ziporin; T L Ennis; S D Shapiro; R M Senior; R W Thompson
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Authors:  Janet C Reid; Admire Matsika; Claire M Davies; Yaowu He; Amy Broomfield; Nigel C Bennett; Viktor Magdolen; Bhuvana Srinivasan; Judith A Clements; John D Hooper
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

8.  The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9.

Authors:  Sylvie Monferran; Jenny Paupert; Stéphanie Dauvillier; Bernard Salles; Catherine Muller
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

9.  Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms.

Authors:  J A Curci; S Liao; M D Huffman; S D Shapiro; R W Thompson
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

10.  Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.

Authors:  Hitesh S Deshmukh; Colleen Shaver; Lisa M Case; Maggie Dietsch; Scott C Wesselkamper; William D Hardie; Thomas R Korfhagen; Massimo Corradi; Jay A Nadel; Michael T Borchers; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-15       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.